What’s new in di­a­betes

Diabetes Care Guide (English) - - CONTENTS -

Amed­i­ca­tion com­monly pre­scribed for treat­ing high blood pres­sure has been as­so­ci­ated with lower fast­ing glu­cose lev­els in di­a­bet­ics. Uni­ver­sity of Alabama at Birm­ing­ham re­searchers stud­ied 5,000 adults with di­a­betes who are part of a larger na­tional study in the U.S. ex­am­in­ing rea­sons for geo­graphic and racial dif­fer­ences in stroke risk. Among the di­a­bet­ics in the sub­group who had type 1 or se­vere type 2 di­a­betes (all tak­ing in­sulin alone or in­sulin with a cal­cium chan­nel blocker med­i­ca­tion), those who also took ve­r­a­pamil had much lower blood glu­cose lev­els than those who didn’t. The study’s au­thors think the re­sults sug­gest that be­cause ve­r­a­pamil seems to be most ac­tive in par­tic­i­pants with type 1 di­a­betes or type 2 with strong beta cell dam­age, the drug may work on a struc­tural level. A fol­low-up clin­i­cal trial is un­der­way.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.